封面
市場調查報告書
商品編碼
1977874

全球居家檢測市場規模、佔有率、趨勢及成長分析報告(2026-2034)

Global At-Home Lab Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年,家庭檢測市場規模將從 2025 年的 95 億美元成長至 127.9 億美元,2026 年至 2034 年的複合年成長率為 3.36%。

由於消費者對便利、私密的醫療保健解決方案的需求日益成長,全球居家檢測市場正在快速擴張。診斷技術的進步使得在家檢測糖尿病、高膽固醇、感染疾病和荷爾蒙失衡等疾病成為可能。人們對預防醫學和數位健康平台的日益重視也是推動市場成長的主要因素。

關鍵成長要素包括遠端醫療的普及、便捷的檢體採集套裝以及透過線上平台快速處理檢測結果。消費者非常青睞無需前往診所或實驗室即可在家中進行檢測的便利性。醫療保健成本的上漲和個人健康意識的增強進一步推動了市場需求。監管部門的核准和檢測準確性的提高也增強了消費者的信心。

展望未來,與行動醫療應用和基於人工智慧的健康追蹤系統的整合預計將對市場產生積極影響。快速檢測技術的持續創新將擴大可檢測疾病的範圍。網路連線和醫療保健服務不斷改善的新興市場具有巨大的成長潛力。隨著個人化醫療日益重要,居家檢測預計將在全球範圍內繼續保持持續成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球家庭檢測市場:依檢測類型分類

  • 市場分析、洞察與預測
  • 血糖檢測套組
  • 傳染病檢查試劑盒
  • 檢測套組
  • 膽固醇試紙
  • 藥物濫用檢測套組
  • 凝血監測測試
  • 其他測試類型

第5章:全球家庭檢測市場:依通路分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥局/藥局
  • 網路藥房

第6章 全球家庭檢測市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第8章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Quest Diagnostics
    • LabCorp
    • Everlywell
    • LetsGetChecked
    • Pixel By LabCorp
    • MyHeritage
    • 23andMe
    • BioIQ
    • Teladoc Health
    • HealthLinkNow
簡介目錄
Product Code: VMR112113715

The At-Home Lab Testing Market size is expected to reach USD 12.79 Billion in 2034 from USD 9.50 Billion (2025) growing at a CAGR of 3.36% during 2026-2034.

The Global At-Home Lab Testing Market is expanding rapidly due to increasing consumer preference for convenient and private healthcare solutions. Advances in diagnostic technology have enabled individuals to conduct tests for conditions such as diabetes, cholesterol, infections, and hormonal imbalances from home. Growing awareness of preventive healthcare and digital health platforms is significantly driving market growth.

Key growth drivers include telehealth expansion, user-friendly sample collection kits, and faster result processing through online platforms. Consumers appreciate the convenience of home testing without visiting clinics or laboratories. Rising healthcare costs and increased focus on personal wellness are further supporting demand. Regulatory approvals and improved test accuracy are also strengthening consumer confidence.

Looking forward, the market is expected to benefit from integration with mobile health apps and AI-based health tracking systems. Continuous innovation in rapid testing technologies will expand the range of detectable conditions. Emerging markets with improving internet connectivity and healthcare access offer substantial growth potential. As personalized healthcare becomes more prominent, at-home lab testing is projected to witness sustained global expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Glucose Test Kits
  • Infectious Diseases Test Kits
  • Pregnancy Test Kits
  • Cholesterol Test Strips
  • Drugs of Abuse Test Kits
  • Coagulation Monitoring Tests
  • Other Test Types

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies/Drug Stores
  • Online Pharmacies

COMPANIES PROFILED

  • Quest Diagnostics, LabCorp, Everlywell, LetsGetChecked, Pixel by LabCorp, MyHeritage, 23andMe, BioIQ, Teladoc Health, HealthLinkNow
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AT-HOME LAB TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Glucose Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Infectious Diseases Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pregnancy Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cholesterol Test Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Drugs of Abuse Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Coagulation Monitoring Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AT-HOME LAB TESTING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Distribution Channel
  • 5.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Retail Pharmacies/Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AT-HOME LAB TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By Distribution Channel
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By Distribution Channel
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By Distribution Channel
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By Distribution Channel
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By Distribution Channel
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL AT-HOME LAB TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Quest Diagnostics
    • 8.2.2 LabCorp
    • 8.2.3 Everlywell
    • 8.2.4 LetsGetChecked
    • 8.2.5 Pixel By LabCorp
    • 8.2.6 MyHeritage
    • 8.2.7 23andMe
    • 8.2.8 BioIQ
    • 8.2.9 Teladoc Health
    • 8.2.10 HealthLinkNow